UK
The Brexit ‘cliff edge’: How life sciences can survive
June 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, brexit, pharma
Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …
One third of Brits stockpile drugs
June 24, 2019Sales and Marketing UK, medicine, pharma, pharmaceuticals, stockpiling
A third (33%) of brits stockpile medicines, according to new research from Co-op Health. One in three British people never …
Alimera Sciences secures NICE recommendation for uveitis eye implant
June 21, 2019Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis
Britain’s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …
No-deal Brexit could cause shortages and higher prices, healthcare distributors warn
June 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain
The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …
AstraZeneca spends more than twice as much as expected on new HQ
June 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma
AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …
Healthcare communications: Time to think differently with patient centricity
June 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Spink, UK, patient centricity, pharma
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand …
Donald Trump causes confusion as to whether NHS will be ‘on the table’ in trade deal talks
June 6, 2019Business Services, Medical Communications Donald Trump, NHS, UK, US, healthcare, pharma
President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit …
Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says
June 3, 2019Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare
The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …
NICE recommends MSD’s Prevymis for CMV prevention following allogeneic haematopoietic stem cell transplant
May 31, 2019Medical Communications, Sales and Marketing MSD, NICE, Prevymis, UK, cmv, cytomegalovirus, pharma
MSD has revealed that its non-nucleoside CMV inhibitor Prevymis (letermovir) has secured recommendation from NICE, meaning it will now be …
Manchester emerges as genomics research hub
May 29, 2019Research and Development Diagnostics, Manchester, UK, genomics, pharma
Manchester, UK is emerging as a major hub for genomics research, according to a new firm set up in collaboration …
Mumps cases triple in England
May 24, 2019Medical Communications MMR, UK, Vaccine, health, public health
Public Health England has urged patients to ensure that they have received the MMR vaccine after the number of cases …
Akcea’s Tegsedi secures NICE approval for Stage 1 or 2 polyneuropathy in hATTR
May 23, 2019Sales and Marketing Akcea Therapeutics, NHS, NICE, Tegsedi, UK, pharma
Akcea Therapeutics’ Tegsedi (inotersen) has received recommendation from NICE, the company has revealed, meaning the therapy will now be made …
GP appointments should be at least 15 minutes long by 2030, report argues
May 21, 2019Manufacturing and Production, Medical Communications GP, NHS, UK, britain, pharma
GP consultations should be five minutes longer, with 10 minute doctors’ appointments being a ‘thing of the past,’ according to …
NICE recommends Celgene’s Revlimid in treatment-naive multiple myeloma
May 20, 2019Sales and Marketing Celgene, NICE, Revlimid, UK, multiple myeloma
Celgene’s Revlimid (lenalidomide) has been recommended by NICE for use on the NHS in England and Wales in combination with …
NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza
May 15, 2019Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy
NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
